Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
- V. Gorgoulis, Leandros-Vassilios F. Vassiliou, +12 authors T. Halazonetis
- Biology, Medicine
- Nature
- 14 April 2005
DNA damage checkpoint genes, such as p53, are frequently mutated in human cancer, but the selective pressure for their inactivation remains elusive. We analysed a panel of human lung hyperplasias,… Expand
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
- J. Tsai, J. T. Lee, +35 authors G. Bollag
- Medicine, Biology
- Proceedings of the National Academy of Sciences
- 26 February 2008
BRAFV600E is the most frequent oncogenic protein kinase mutation known. Furthermore, inhibitors targeting “active” protein kinases have demonstrated significant utility in the therapeutic repertoire… Expand
High-throughput oncogene mutation profiling in human cancer
- R. Thomas, Alissa C. Baker, +50 authors L. Garraway
- Biology, Medicine
- Nature Genetics
- 1 March 2007
Systematic efforts are underway to decipher the genetic changes associated with tumor initiation and progression. However, widespread clinical application of this information is hampered by an… Expand
A tumorigenic subpopulation with stem cell properties in melanomas.
- Dong Fang, T. K. Nguyen, +7 authors M. Herlyn
- Biology, Medicine
- Cancer research
- 15 October 2005
Recent studies suggest that cancer can arise from a cancer stem cell (CSC), a tumor-initiating cell that has properties similar to those of stem cells. CSCs have been identified in several… Expand
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.
- K. Hoek, Natalie C Schlegel, +9 authors R. Dummer
- Biology, Medicine
- Pigment cell research
- 1 August 2006
The molecular biology of metastatic potential in melanoma has been studied many times previously and changes in the expression of many genes have been linked to metastatic behaviour. What is lacking… Expand
BRAF and RAS mutations in human lung cancer and melanoma.
BRAF encodes a RAS-regulated kinase that mediates cell growth and malignant transformation kinase pathway activation. Recently, we have identified activating BRAF mutations in 66% of melanomas and a… Expand
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- A. Rösch, M. Fukunaga-Kalabis, +7 authors M. Herlyn
- Biology, Medicine
- Cell
- 14 May 2010
Melanomas are highly heterogeneous tumors, but the biological significance of their different subpopulations is not clear. Using the H3K4 demethylase JARID1B (KDM5B/PLU-1/RBP2-H1) as a biomarker, we… Expand
Akt/Protein Kinase B Signaling Inhibitor-2, a Selective Small Molecule Inhibitor of Akt Signaling with Antitumor Activity in Cancer Cells Overexpressing Akt
Accumulated studies have shown that activation of the Akt pathway plays a pivotal role in malignant transformation and chemoresistance by inducing cell survival, growth, migration, and angiogenesis.… Expand
Regulation of Notch1 and Dll4 by Vascular Endothelial Growth Factor in Arterial Endothelial Cells: Implications for Modulating Arteriogenesis and Angiogenesis
- Z. Liu, T. Shirakawa, +6 authors M. Herlyn
- Biology, Medicine
- Molecular and Cellular Biology
- 1 January 2003
ABSTRACT Notch and its ligands play critical roles in cell fate determination. Expression of Notch and ligand in vascular endothelium and defects in vascular phenotypes of targeted mutants in the… Expand
Exosomal PD-L1 Contributes to Immunosuppression and is Associated with anti-PD-1 Response
Tumour cells evade immune surveillance by upregulating the surface expression of programmed death-ligand 1 (PD-L1), which interacts with programmed death-1 (PD-1) receptor on T cells to elicit the… Expand